NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BigHat Biosciences

BigHat Biosciences

Private
San Mateo, CaliforniaHealthcare & Life Scienceshttps://www.bighatbio.com/

Last Round

Series B

Apr 28, 2025

Est. Valuation

$304.1M

Total Funding Raised

$228.8M

Company Overview

BigHat Biosciences is a biotechnology company that develops AI-guided protein therapeutic platforms to engineer safer and more effective antibody therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, ML Platforms, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

antibody discoverybiologics discoveryprotein engineeringAI drug discoveryin silico drug designantibody designgenerative biologymachine learningwet-lab automationtherapeutic antibodiesdrug discovery platformprotein optimizationbiotech R&DAI-first drug discoverylaboratory information management systemLIMS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BigHat Biosciences Comparables

Compare BigHat Biosciences with similar companies based on industry and business-model similarity.

BigHat Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

BigHat Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BApr 28, 2025
Series BJul 20, 2022
Series AFeb 10, 2021
GrantNov 1, 2020
SeedDec 19, 2019
Seed
Oct 22, 2019

Key People

Founding team and executive leadership

Peyton Greenside

Founder And CSO, CEO, President

Founding Team

BigHat Biosciences Investors

Notable investors and investment history

BigHat Biosciences investors
InvestorRounds
Andreessen HorowitzSeries B, Series A
S32Series B
Innovation EndeavorsSeries A, Seed
GaingelsSeries B
M VenturesSeries B, Series A
Intermountain VenturesSeries B
Quain InvestmentsSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 28, 2025

    $124M round raised at $304M post-money valuation.

  • Jul 20, 2022

    $75M Series B round completed.

BigHat Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BigHat Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BigHat Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Mateo, California
Employee Range97
Year Founded2019
Last FundingApr 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.